{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Rockford",
      "state": "IL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA076187"
        ],
        "brand_name": [
          "LEVOTHYROXINE SODIUM"
        ],
        "generic_name": [
          "LEVOTHYROXINE SODIUM"
        ],
        "manufacturer_name": [
          "Mylan Institutional Inc."
        ],
        "product_ndc": [
          "42292-038",
          "42292-039",
          "42292-041",
          "42292-040"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "LEVOTHYROXINE SODIUM"
        ],
        "rxcui": [
          "966248",
          "966249",
          "966253",
          "966270"
        ],
        "spl_id": [
          "3a991bf1-d9aa-b137-e063-6294a90af2cf"
        ],
        "spl_set_id": [
          "cd69c192-cd3f-47e6-b0a6-c536ffed5c4b"
        ],
        "package_ndc": [
          "42292-038-01",
          "42292-038-20",
          "42292-039-01",
          "42292-039-20",
          "42292-041-01",
          "42292-041-20",
          "42292-040-01",
          "42292-040-20"
        ],
        "original_packager_product_ndc": [
          "0378-1807",
          "0378-1811",
          "0378-1823",
          "0378-1817"
        ],
        "unii": [
          "9J765S329G"
        ]
      },
      "product_type": "Drugs",
      "event_id": "95817",
      "recalling_firm": "Mylan Institutional, Inc.",
      "address_1": "1718 Northrock Ct",
      "address_2": "",
      "postal_code": "61103-1201",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA.",
      "recall_number": "D-0134-2025",
      "product_description": "Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA.  NDC: 42292-041-20",
      "product_quantity": "1,133 cartons",
      "reason_for_recall": "Subpotent and Superpotent Drug",
      "recall_initiation_date": "20241119",
      "center_classification_date": "20241212",
      "report_date": "20241218",
      "code_info": "Lot #: 3115448, Exp. Date 12/31/2024;3115732, Exp. Date  3/31/2025;  3116024, Exp. Date 9/30/2025",
      "more_code_info": ""
    }
  ]
}